4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Metis TechBio Co., Ltd. (7666) operates in the Biotechnology industry and is headquartered in Beijing, China with about 150 employees. Its market capitalization is roughly HK$21 billion. In the fiscal year ended 2025-12-31, 7666 reported CNY 105M in revenue and (CNY 392M) in net income.
Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.
Interactive charts & full statements → Open the 7666 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 105M | CNY 2M | CNY 9M | CNY 1M |
| Gross Profit | CNY 103M | CNY 1M | CNY 6M | CNY 0M |
| Operating Income (EBIT) | (CNY 354M) | (CNY 380M) | (CNY 393M) | (CNY 377M) |
| Net Income | (CNY 392M) | (CNY 499M) | (CNY 582M) | (CNY 512M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 |
|---|---|
| Total Revenue | CNY 3M |
| Gross Profit | CNY 2M |
| Operating Income (EBIT) | (CNY 142M) |
| Net Income | (CNY 145M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.0B | CNY 1.3B | CNY 617M |
| Total Liabilities | CNY 249M | CNY 2.4B | CNY 2.3B | CNY 707M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 7666 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms